Zentrum für Gastroenterologie Saar MVZ GmbH
Saarbrucken, Germany
Gastroenterologist in Saarbrücken, Saarland
Dudweilerstraße 2a, 66111 Saarbrücken
About Zentrum für Gastroenterologie Saar MVZ GmbH
"Medizinisches Versorgungszentrum für Gastroenterologie, insbesondere Darmerkrankungen"
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Janssen Research & Development, LLC
4
Cristcot LLC
1
Janssen-Cilag Ltd.
1
Clinical Trials at Zentrum für Gastroenterologie Saar MVZ GmbH
During the past decade, Zentrum für Gastroenterologie Saar MVZ GmbH conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
2018-04-13
2030-06-30
Active, not recruiting
1,409
A Study to Evaluate Efficacy and Safety of Ustekinumab Re-induction Therapy in Participants With Moderately to Severely Active Crohn's Disease
2018-12-20
2023-01-10
Completed
215
A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis
2019-09-26
2029-09-29
Active, not recruiting
1,064
Phase 3 Study to Evaluate the Safety and Efficacy of Hydrocortisone Acetate Suppositories
2020-12-10
2023-12-31
Recruiting
618
A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease
2022-07-22
2030-10-08
Recruiting
715
A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
2022-09-19
2030-09-27
Recruiting
550
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Zentrum für Gastroenterologie Saar MVZ GmbH"
#1 collaborator was "Cristcot HCA LLC" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Zentrum für Gastroenterologie Saar MVZ GmbH
According to Clinical.Site data, the most researched conditions in "Zentrum für Gastroenterologie Saar MVZ GmbH" are
"Crohn's Disease" (2 trials), "Colitis, Ulcerative" (1 trials), "Crohn Disease" (1 trials), "Ulcerative Colitis" (1 trials) and "Ulcerative Proctitis" (1 trials). Many other conditions were trialed in "Zentrum für Gastroenterologie Saar MVZ GmbH" in a lesser frequency.
Clinical Trials Intervention Types at Zentrum für Gastroenterologie Saar MVZ GmbH
Most popular intervention types in "Zentrum für Gastroenterologie Saar MVZ GmbH" are "Drug" (5 trials), "Biological" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.
The name of intervention was led by "Guselkumab" (4 trials), "Placebo" (4 trials), "Golimumab" (2 trials), "JNJ-78934804" (2 trials) and "Guselkumab Dose 1" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Zentrum für Gastroenterologie Saar MVZ GmbH
The vast majority of trials in "Zentrum für Gastroenterologie Saar MVZ GmbH" are
6 trials for "All" genders.
Clinical Trials Status at Zentrum für Gastroenterologie Saar MVZ GmbH
Currently, there are NaN active trials in "Zentrum für Gastroenterologie Saar MVZ GmbH".
undefined are not yet recruiting,
3 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Zentrum für Gastroenterologie Saar MVZ GmbH,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Zentrum für Gastroenterologie Saar MVZ GmbH, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".